A phase 1b study of trametinib, an oral Mitogen-activated protein kinase kinase (MEK) inhibitor, in combination with gemcitabine in advanced solid tumours
| author |
|
| created | [InstanceEdit:9653015] Rothfels, Karen, 2019-07-09 |
| dbId | 9653011 |
| displayName | A phase 1b study of trametinib, an oral Mitogen-activated protein kinase kinase (MEK) inhibitor, in combination with gemcitabine in advanced solid tumours |
| journal | Eur. J. Cancer |
| pages | 2077-85 |
| pubMedIdentifier | 23583440 |
| schemaClass | LiteratureReference |
| title | A phase 1b study of trametinib, an oral Mitogen-activated protein kinase kinase (MEK) inhibitor, in combination with gemcitabine in advanced solid tumours |
| url | http://www.ncbi.nlm.nih.gov/pubmed/23583440 |
| volume | 49 |
| year | 2013 |
Referrals
© 2026 Reactome
